Collins, C., Carducci, M. A., Eisenberger, M. A., Isaacs, J. T., Partin, A. W., Pili, R., . . . Denmeade, S. R. (2007). Preclinical and Clinical Studies with the Multi-Kinase Inhibitor CEP-701 as Treatment for Prostate Cancer Demonstrate the Inadequacy of PSA Response as a Primary Endpoint.
শিকাগো স্টাইলে সাইটেশনCollins, Connie, Michael A. Carducci, Mario A. Eisenberger, John T. Isaacs, Alan W. Partin, Roberto Pili, Victoria J. Sinibaldi, Janet S. Walczak, এবং Samuel R. Denmeade. Preclinical and Clinical Studies With the Multi-Kinase Inhibitor CEP-701 As Treatment for Prostate Cancer Demonstrate the Inadequacy of PSA Response As a Primary Endpoint. 2007.
এমএলএ সাইটেশনCollins, Connie, et al. Preclinical and Clinical Studies With the Multi-Kinase Inhibitor CEP-701 As Treatment for Prostate Cancer Demonstrate the Inadequacy of PSA Response As a Primary Endpoint. 2007.